Given the massive setback to progress in reaching tuberculosis targets, it is crucial to leverage COVID-19 innovations and systems to improve tuberculosis care and control.
Read more: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00057-4/fulltext